Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
CLBT vs AXON vs SPSC vs SAIC vs LDOS
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
Software - Infrastructure
Information Technology Services
Information Technology Services
CLBT vs AXON vs SPSC vs SAIC vs LDOS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Aerospace & Defense | Software - Infrastructure | Information Technology Services | Information Technology Services |
| Market Cap | $3.38B | $34.40B | $2.14B | $4.24B | $16.51B |
| Revenue (TTM) | $476M | $2.98B | $762M | $7.26B | $17.48B |
| Net Income (TTM) | $78M | $206M | $91M | $358M | $1.36B |
| Gross Margin | 84.2% | 59.3% | 68.0% | 12.0% | 17.3% |
| Operating Margin | 14.0% | 1.3% | 15.3% | 7.1% | 11.6% |
| Forward P/E | 37.5x | 55.0x | 12.7x | 9.3x | 11.1x |
| Total Debt | $23M | $1.91B | $10M | $217M | $5.93B |
| Cash & Equiv. | $124M | $1.20B | $151M | $182M | $1.20B |
CLBT vs AXON vs SPSC vs SAIC vs LDOS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Cellebrite DI Ltd. (CLBT) | 100 | 138.7 | +38.7% |
| Axon Enterprise, In… (AXON) | 100 | 339.6 | +239.6% |
| SPS Commerce, Inc. (SPSC) | 100 | 55.5 | -44.5% |
| Science Application… (SAIC) | 100 | 101.7 | +1.7% |
| Leidos Holdings, In… (LDOS) | 100 | 130.3 | +30.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLBT vs AXON vs SPSC vs SAIC vs LDOS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLBT ranks third and is worth considering specifically for growth exposure.
- Rev growth 18.6%, EPS growth 123.0%, 3Y rev CAGR 20.7%
- 16.5% margin vs SAIC's 4.9%
AXON is the clearest fit if your priority is long-term compounding.
- 22.0% 10Y total return vs LDOS's 223.8%
- 33.5% revenue growth vs SAIC's -2.9%
Among these 5 stocks, SPSC doesn't own a clear edge in any measured category.
SAIC carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.26, yield 1.6%
- Lower volatility, beta 0.26, Low D/E 14.5%, current ratio 1.20x
- Beta 0.26, yield 1.6%, current ratio 1.20x
- Lower P/E (9.3x vs 12.7x), PEG 0.56 vs 0.89
LDOS is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.54 vs SPSC's 0.89
- -14.1% vs SPSC's -59.7%
- 9.4% ROA vs AXON's 3.1%, ROIC 17.1% vs -1.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 33.5% revenue growth vs SAIC's -2.9% | |
| Value | Lower P/E (9.3x vs 12.7x), PEG 0.56 vs 0.89 | |
| Quality / Margins | 16.5% margin vs SAIC's 4.9% | |
| Stability / Safety | Beta 0.26 vs AXON's 1.19, lower leverage | |
| Dividends | 1.6% yield, 2-year raise streak, vs LDOS's 1.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | -14.1% vs SPSC's -59.7% | |
| Efficiency (ROA) | 9.4% ROA vs AXON's 3.1%, ROIC 17.1% vs -1.3% |
CLBT vs AXON vs SPSC vs SAIC vs LDOS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CLBT vs AXON vs SPSC vs SAIC vs LDOS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SAIC leads in 2 of 6 categories
CLBT leads 1 • LDOS leads 1 • AXON leads 0 • SPSC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CLBT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LDOS is the larger business by revenue, generating $17.5B annually — 36.7x CLBT's $476M. CLBT is the more profitable business, keeping 16.5% of every revenue dollar as net income compared to SAIC's 4.9%. On growth, AXON holds the edge at +33.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $476M | $3.0B | $762M | $7.3B | $17.5B |
| EBITDAEarnings before interest/tax | $78M | $97M | $162M | $666M | $2.2B |
| Net IncomeAfter-tax profit | $78M | $206M | $91M | $358M | $1.4B |
| Free Cash FlowCash after capex | $160M | $20M | $167M | $609M | $1.7B |
| Gross MarginGross profit ÷ Revenue | +84.2% | +59.3% | +68.0% | +12.0% | +17.3% |
| Operating MarginEBIT ÷ Revenue | +14.0% | +1.3% | +15.3% | +7.1% | +11.6% |
| Net MarginNet income ÷ Revenue | +16.5% | +6.9% | +11.9% | +4.9% | +7.8% |
| FCF MarginFCF ÷ Revenue | +33.7% | +0.7% | +21.9% | +8.4% | +9.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.1% | +33.7% | +5.8% | -4.8% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +89.8% | -8.6% | -6.5% | -7.6% |
Valuation Metrics
SAIC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.8x trailing earnings, LDOS trades at a 96% valuation discount to AXON's 282.7x P/E. Adjusting for growth (PEG ratio), LDOS offers better value at 0.57x vs SPSC's 1.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.4B | $34.4B | $2.1B | $4.2B | $16.5B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $35.1B | $2.0B | $4.3B | $21.2B |
| Trailing P/EPrice ÷ TTM EPS | 44.55x | 282.71x | 23.24x | 12.22x | 11.79x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.53x | 54.97x | 12.73x | 9.33x | 11.08x |
| PEG RatioP/E ÷ EPS growth rate | 0.76x | — | 1.62x | 0.73x | 0.57x |
| EV / EBITDAEnterprise value multiple | 41.79x | 1664.88x | 11.30x | 6.43x | 8.82x |
| Price / SalesMarket cap ÷ Revenue | 7.10x | 12.37x | 2.84x | 0.58x | 0.96x |
| Price / BookPrice ÷ Book value/share | 7.13x | 13.16x | 2.23x | 2.92x | 3.50x |
| Price / FCFMarket cap ÷ FCF | 21.06x | 458.11x | 14.04x | 7.34x | 10.16x |
Profitability & Efficiency
LDOS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LDOS delivers a 27.1% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $7 for AXON. SPSC carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to LDOS's 1.19x. On the Piotroski fundamental quality scale (0–9), LDOS scores 8/9 vs CLBT's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.2% | +6.6% | +9.5% | +23.7% | +27.1% |
| ROA (TTM)Return on assets | +8.3% | +3.1% | +7.9% | +6.8% | +9.4% |
| ROICReturn on invested capital | +18.5% | -1.3% | +12.2% | +14.2% | +17.1% |
| ROCEReturn on capital employed | +13.8% | -1.5% | +12.5% | +12.5% | +21.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.05x | 0.59x | 0.01x | 0.14x | 1.19x |
| Net DebtTotal debt minus cash | -$102M | $709M | -$141M | $35M | $4.7B |
| Cash & Equiv.Liquid assets | $124M | $1.2B | $151M | $182M | $1.2B |
| Total DebtShort + long-term debt | $23M | $1.9B | $10M | $217M | $5.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 1.18x | — | 3.99x | 9.91x |
Total Returns (Dividends Reinvested)
Evenly matched — CLBT and AXON each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AXON five years ago would be worth $31,683 today (with dividends reinvested), compared to $5,811 for SPSC. Over the past 12 months, LDOS leads with a -14.1% total return vs SPSC's -59.7%. The 3-year compound annual growth rate (CAGR) favors CLBT at 36.3% vs SPSC's -28.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -22.6% | -24.2% | -35.0% | -6.3% | -28.2% |
| 1-Year ReturnPast 12 months | -27.6% | -29.1% | -59.7% | -20.9% | -14.1% |
| 3-Year ReturnCumulative with dividends | +153.4% | +92.4% | -62.6% | -0.8% | +71.9% |
| 5-Year ReturnCumulative with dividends | +39.9% | +216.8% | -41.9% | +12.4% | +33.4% |
| 10-Year ReturnCumulative with dividends | +43.0% | +2200.0% | +119.8% | +104.4% | +223.8% |
| CAGR (3Y)Annualised 3-year return | +36.3% | +24.4% | -28.0% | -0.3% | +19.8% |
Risk & Volatility
SAIC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SAIC is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than AXON's 1.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SAIC currently trades 75.8% from its 52-week high vs SPSC's 37.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 1.19x | 1.03x | 0.26x | 0.42x |
| 52-Week HighHighest price in past year | $20.45 | $885.92 | $153.16 | $124.11 | $205.77 |
| 52-Week LowLowest price in past year | $11.02 | $339.01 | $50.56 | $81.08 | $129.35 |
| % of 52W HighCurrent price vs 52-week peak | +67.5% | +48.2% | +37.3% | +75.8% | +63.8% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 40.5 | 46.9 | 46.3 | 24.5 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 1.0M | 605K | 563K | 1.0M |
Analyst Outlook
Evenly matched — SAIC and LDOS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CLBT as "Buy", AXON as "Buy", SPSC as "Hold", SAIC as "Hold", LDOS as "Buy". Consensus price targets imply 70.2% upside for AXON (target: $727) vs 3.6% for SAIC (target: $98). For income investors, SAIC offers the higher dividend yield at 1.60% vs LDOS's 1.21%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $20.67 | $726.71 | $68.71 | $97.50 | $204.00 |
| # AnalystsCovering analysts | 8 | 21 | 23 | 18 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +1.6% | +1.2% |
| Dividend StreakConsecutive years of raises | 1 | — | — | 2 | 5 |
| Dividend / ShareAnnual DPS | — | — | — | $1.51 | $1.59 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +5.3% | +10.5% | +5.7% |
SAIC leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). CLBT leads in 1 (Income & Cash Flow). 2 tied.
CLBT vs AXON vs SPSC vs SAIC vs LDOS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CLBT or AXON or SPSC or SAIC or LDOS a better buy right now?
For growth investors, Axon Enterprise, Inc.
(AXON) is the stronger pick with 33. 5% revenue growth year-over-year, versus -2. 9% for Science Applications International Corporation (SAIC). Leidos Holdings, Inc. (LDOS) offers the better valuation at 11. 8x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Cellebrite DI Ltd. (CLBT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLBT or AXON or SPSC or SAIC or LDOS?
On trailing P/E, Leidos Holdings, Inc.
(LDOS) is the cheapest at 11. 8x versus Axon Enterprise, Inc. at 282. 7x. On forward P/E, Science Applications International Corporation is actually cheaper at 9. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Leidos Holdings, Inc. wins at 0. 54x versus SPS Commerce, Inc. 's 0. 89x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CLBT or AXON or SPSC or SAIC or LDOS?
Over the past 5 years, Axon Enterprise, Inc.
(AXON) delivered a total return of +216. 8%, compared to -41. 9% for SPS Commerce, Inc. (SPSC). Over 10 years, the gap is even starker: AXON returned +22. 0% versus CLBT's +43. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLBT or AXON or SPSC or SAIC or LDOS?
By beta (market sensitivity over 5 years), Science Applications International Corporation (SAIC) is the lower-risk stock at 0.
26β versus Axon Enterprise, Inc. 's 1. 19β — meaning AXON is approximately 351% more volatile than SAIC relative to the S&P 500. On balance sheet safety, SPS Commerce, Inc. (SPSC) carries a lower debt/equity ratio of 1% versus 119% for Leidos Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CLBT or AXON or SPSC or SAIC or LDOS?
By revenue growth (latest reported year), Axon Enterprise, Inc.
(AXON) is pulling ahead at 33. 5% versus -2. 9% for Science Applications International Corporation (SAIC). On earnings-per-share growth, the picture is similar: Cellebrite DI Ltd. grew EPS 123. 0% year-over-year, compared to -68. 5% for Axon Enterprise, Inc.. Over a 3-year CAGR, AXON leads at 32. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLBT or AXON or SPSC or SAIC or LDOS?
Cellebrite DI Ltd.
(CLBT) is the more profitable company, earning 16. 5% net margin versus 4. 5% for Axon Enterprise, Inc. — meaning it keeps 16. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPSC leads at 15. 7% versus -2. 2% for AXON. At the gross margin level — before operating expenses — CLBT leads at 84. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLBT or AXON or SPSC or SAIC or LDOS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Leidos Holdings, Inc. (LDOS) is the more undervalued stock at a PEG of 0. 54x versus SPS Commerce, Inc. 's 0. 89x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Science Applications International Corporation (SAIC) trades at 9. 3x forward P/E versus 55. 0x for Axon Enterprise, Inc. — 45. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AXON: 70. 2% to $726. 71.
08Which pays a better dividend — CLBT or AXON or SPSC or SAIC or LDOS?
In this comparison, SAIC (1.
6% yield), LDOS (1. 2% yield) pay a dividend. CLBT, AXON, SPSC do not pay a meaningful dividend and should not be held primarily for income.
09Is CLBT or AXON or SPSC or SAIC or LDOS better for a retirement portfolio?
For long-horizon retirement investors, Science Applications International Corporation (SAIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
26), 1. 6% yield, +104. 4% 10Y return). Both have compounded well over 10 years (SAIC: +104. 4%, AXON: +22. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLBT and AXON and SPSC and SAIC and LDOS?
These companies operate in different sectors (CLBT (Technology) and AXON (Industrials) and SPSC (Technology) and SAIC (Technology) and LDOS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CLBT is a small-cap high-growth stock; AXON is a mid-cap high-growth stock; SPSC is a small-cap high-growth stock; SAIC is a small-cap deep-value stock; LDOS is a mid-cap deep-value stock. SAIC, LDOS pay a dividend while CLBT, AXON, SPSC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.